Fuad Shihab, MD
Enriched profileProfessor of Medicine, Division of Nephrology · University of Utah
Fuad Shihab is Professor of Medicine, Division of Nephrology at University of Utah. OpenAlex indexes 130 publications with 4,813 citations (h-index 36); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 11 Oct 2026
Overview
Updated 16 Oct 2026
Fuad Shihab, MD, is Professor of Medicine, Division of Nephrology at University of Utah. The public record shows 130 publications with 4,813 citations (h-index 36), centered on Renal Transplantation Outcomes and Treatments, Transplantation: Methods and Outcomes, Organ Donation and Transplantation. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 16 companies, 1 NIH-funded awards (2004–2004).
- Most recent indexed publication: 2026 · Journal of the American Society of Nephrology
- Top research focus: Renal Transplantation Outcomes and Treatments
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 16 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 76.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State
Sponsor: University of Utah
Industry payments
Updated 16 Oct 2026
16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20256 payments
- ZOLL Medical CorporationProgram year20251 payment
- Alexion Pharmaceuticals, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
56.5%Angiotensin receptor blocker (ARB)21.5%Losartan Potassium100%Part D≥31 patientsLoop diuretic10.6%Furosemide100%Part D≥15 patients+ 5 more classes in this area
Metabolism & gastrointestinal
40.2%SGLT2 inhibitor20.7%Farxiga58%Jardiance42%Part D<11 patientsVitamin D3 Analog13.6%Calcitriol100%Part D≥20 patients+ 2 more classes in this area
Genitourinary & hormones
3.3%alpha-Adrenergic Blocker3.3%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
1 NIH research award on record, funded 2004–2004 per NIH RePORTER. The latest:
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation.
Journal of the American Society of Nephrology
Article2026 - Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians.
Annals of transplantation
Article2024 - Kidney transplantation from SARS-CoV-2-positive deceased donor.
American journal of transplantation
Letter2022
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathyArticle214 citations1996
- 04Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathyArticle209 citations1997
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
medicine.utah.edu/internal-medicine/news/2024/07/dr-fuad-shihab-appointed-abstract-category-chair-2024-asn-kidney
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.utah.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
American University of Beirut
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.utah.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.utah.edu ↗
- Nephrology fellowship
University of Pennsylvania; Transplantation Medicine fellowship, Oregon Health and Science University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.utah.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.utah.edu ↗
- Associate Editor
Clinical Transplantation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.utah.edu ↗ - Past President
American Foundation for Donation and Transplantation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.utah.edu ↗
Awards & honors
honors on the public record- Faculty Teaching Awards
University of Utah School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.utah.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Colman, MD
University of Utah
James Fang
University of Utah
Frederick Welt, MD
University of Utah
Jennifer Majersik, MD
University of Utah
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)